Paper

4-ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin.

Published Jul 11, 2020 · DOI · M. Campbell, Chih-Yun Cho, A. Ho

International journal of antimicrobial agents

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

4-ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and enhances biofilm sensitivity to vancomycin, making it a potential anti-pathogenic, anti-biofilm agent for prevention and treatment.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

4-ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin.

References

Citations